Amended Current Report Filing (8-k/a)
December 20 2016 - 10:35AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 12, 2016
IMMUDYNE,
INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
333-184487
|
|
76-0238453
|
(State
or other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
|
50
Spring Meadow Rd.
Mount
Kisco, NY
|
|
10549
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(914) 244-1777
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
EXPLANATORY
NOTE
This
Form 8-K/A is being filed to correct a typographical error in the original Immudyne, Inc. corporate presentation filed on December
12, 2016.
Item
7.01. Regulation FD Disclosure
On
December 12, 2016, Immudyne, Inc. released a new corporate presentation. Attached hereto as Exhibit 99.1 and made part of this
report, is a copy of this presentation.
Pursuant
to General Instruction B.2. to Form 8-K, the information set forth in this Item 7.01 and Exhibit 99.1 shall not be deemed “filed”
for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, or incorporated by reference
in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such
a filing.
Item
9.01. Financial Statements and Exhibits
|
(d)
|
|
Exhibits
|
|
|
|
|
|
99.1
|
|
Immudyne,
Inc. corporate presentation Q4 2016 (furnished only)
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
IMMUDYNE
INC.
|
|
|
(Registrant)
|
|
|
|
|
Date:
December 20, 2016
|
By:
|
/s/
Mark McLaughlin
|
|
|
Name:
|
Mark
McLaughlin
|
|
|
Title:
|
Chief
Executive Officer
|
3